TIME | ARTICLE |
JOURNAL |
IF | PUBMED ID | PRODUCT |
---|---|---|---|---|---|
2022 | Dual inhibition of TGFβ signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1 | Cancer Letters | 9.5 | 35718267 | |
2022 | Matrix metalloproteinase-7 promotes chronic kidney disease progression via the induction of inflammasomes and the suppression of autophagy | Biomedicine & Pharmacotherapy | 7.419 | 36007272 | |
2022 | Dicer-mediated miR-200b expression contributes to cell migratory/ invasive abilities and cancer stem cells properties of breast cancer cells | AGING | 5.682 | 35951366 | |
2022 | IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis | Cell & Bioscience | 9.5 | 35941699 | |
2022 | Comparing different surface modifications of zinc oxide nanoparticles in the developmental toxicity of zebrafish embryos and larvae | Ecotoxicology and Environmental Safety | 7.129 | 35985197 | |
2022 | Lidocaine Inhibited Tendon Cell Proliferation and Extracellular Matrix Production by Down Regulation of Cyclin A, CDK2, Type I and Type III Collagen Expression | International Journal of Molecular Sciences | 6.2 | 35955918 | |
2022 | Dicer-mediated miR-200b expression contributes to cell migratory/ invasive abilities and cancer stem cells properties of breast cancer cells | Aging | 5.682 | 35951366 | |
2022 | LPAL2 suppresses tumor growth and metastasis of hepatocellular carcinoma by modulating MMP9 expression | Cells | 7.666 | 36010685 | |
2022 | CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance | Clinical Epigenetics | 7.259 | 35999564 |